ScoreWhy is Mizuho Medy Co., Ltd. ?
1
High Management Efficiency with a high ROE of 37.40%
2
Company has very low debt and has enough cash to service the debt requirements
3
Healthy long term growth as Net Sales has grown by an annual rate of 21.78% and Operating profit at 62.02%
4
Positive results in Mar 26
- NET SALES(HY) At JPY 7,242 MM has Grown at 18.94%
- CASH AND EQV(HY) Highest at JPY 23,362 MM
- DEBT-EQUITY RATIO (HY) Lowest at -68.38 %
5
With ROE of 18.35%, it has a very attractive valuation with a 1.88 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 9.59%, its profits have fallen by -9.2%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Mizuho Medy Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Mizuho Medy Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Mizuho Medy Co., Ltd.
-100.0%
-0.27
16.32%
Japan Nikkei 225
71.75%
2.62
26.55%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
21.78%
EBIT Growth (5y)
62.02%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
0.65
Tax Ratio
26.30%
Dividend Payout Ratio
55.62%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
112.71%
ROE (avg)
37.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.88
EV to EBIT
5.25
EV to EBITDA
4.96
EV to Capital Employed
3.10
EV to Sales
2.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
59.13%
ROE (Latest)
18.35%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET SALES(HY)
At JPY 7,242 MM has Grown at 18.94%
CASH AND EQV(HY)
Highest at JPY 23,362 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -68.38 %
DEBTORS TURNOVER RATIO(HY)
Highest at 3.32 times
-2What is not working for the Company
NET SALES(Q)
At JPY 2,208 MM has Fallen at -16.65%
Here's what is working for Mizuho Medy Co., Ltd.
Cash and Eqv
Highest at JPY 23,362 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -68.38 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 3.32 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at JPY 69 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for Mizuho Medy Co., Ltd.
Net Sales
At JPY 2,208 MM has Fallen at -16.65%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (JPY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
